Bios Partners logo

Bios Partners

North America, Texas, United States, Fort Worth

Description

Bios Partners is a private equity firm based in Dallas/Fort Worth.

Investor Profile

Bios Partners has made 16 investments, with 1 in the past 12 months and 63% as lead.

Stage Focus

  • Series B (38%)
  • Series A (31%)
  • Series C (6%)
  • Convertible Note (6%)
  • Post Ipo Equity (6%)
  • Seed (6%)
  • Series D (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Alternative Medicine
  • Consumer Goods
  • Biopharma
  • Life Science
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bios Partners frequently co-invest with?

KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 2
Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 2
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 3
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 3
PC
North America, New York, United States, New York
Co-Investments: 2
M
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
DEFTA Partners
North America, California, United States, San Francisco
Co-Investments: 3
InFocus Capital Partners
North America, New York, United States, Jericho
Co-Investments: 2
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 2
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 2

What are some of recent deals done by Bios Partners?

ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DSep 13, 2024
Amount Raised: $65,000,000
Aileron Therapeutics

Cambridge, Massachusetts, United States

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityOct 31, 2023
Amount Raised: $18,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
Opus Genetics

Raleigh, North Carolina, United States

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

Health CareHealth DiagnosticsWellness
SeedSep 22, 2021
Amount Raised: $19,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 22, 2020
Amount Raised: $46,900,000
Azitra

Branford, Connecticut, United States

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Alternative MedicineBiotechnologyConsumer GoodsHealth Care
Series BOct 15, 2020
Amount Raised: $17,000,000
Actuate Therapeutics

Fort Worth, Texas, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

BiotechnologyMedicalPharmaceutical
Series BNov 12, 2019
Amount Raised: $6,500,000
Azitra

Branford, Connecticut, United States

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Alternative MedicineBiotechnologyConsumer GoodsHealth Care
Series AOct 15, 2019
Amount Raised: $14,000,000
Trefoil Therapeutics

San Diego, California, United States

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

BiotechnologyHealth CareTherapeutics
Series AJul 16, 2019
Amount Raised: $28,000,000
Actuate Therapeutics

Fort Worth, Texas, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

BiotechnologyMedicalPharmaceutical
Series BMay 17, 2019
Amount Raised: $21,700,000